Infectious Diseases and Health Access in Nepal
Infectious Diseases and Health Access in Nepal
The high prevalence of infectious diseases in Nepal's Terai region is attributed to several factors including poverty, lack of access to clean water, and inadequate healthcare infrastructure. Many diseases are preventable and treatable, such as diarrhea and respiratory infections, yet they cause high mortality due to these socio-economic factors . Furthermore, the diversity in disease distribution and the presence of asymptomatic carriers exacerbate the spread .
International organizations such as the WHO and UNICEF have played a critical role in reducing disease prevalence in Nepal by implementing health programs focused on maternal and child health. These programs contributed to the decreased prevalence of neonatal disorders, lower respiratory infections, and diarrheal diseases from 1990 to 2017 . Their involvement facilitated improvements in healthcare delivery and public health education, which significantly impacted disease control .
Socio-economic factors profoundly impact healthcare challenges in Nepal's remote regions. Poverty limits individuals' ability to afford transportation to healthcare facilities and buy medications, while inadequate infrastructure restricts both access to, and quality of, healthcare services. These challenges are further compounded by limited educational opportunities, which affect public awareness and health literacy, undermining preventive measures and early diagnosis .
Improving the distribution of essential medicines in Nepal's rural areas can be achieved by strengthening infrastructure, such as better supply chains and transportation networks, to ensure consistent delivery. Expanding healthcare facilities with more staff and increasing the number of essential medicines available at health and sub-health posts can also help . Moreover, incentivizing pharmaceutical companies to focus on affordable solutions for low-income populations could further improve accessibility .
The rise of non-communicable diseases in Nepal reflects a larger global health trend where chronic diseases are becoming more prevalent in developing countries due to lifestyle changes and urbanization. These trends correlate with global priorities shifting towards addressing the growing burden of chronic diseases alongside infectious diseases. In Nepal, this shift is visible in the increasing rates of diseases such as diabetes and ischemic heart disease, as infrastructure and policy investments adapt to these evolving health needs .
The lack of access to essential medicines in rural Nepal results in poorer healthcare outcomes, as individuals are deprived of necessary treatments for both infectious and non-infectious diseases. This situation is exacerbated by the government's inability to fully reach rural areas despite efforts such as distributing free medicines to health posts . Moreover, the high costs of new medicines used for bacterial infections and malaria remain unaffordable for low-income populations .
There has been an increasing trend in non-communicable diseases such as ischemic heart disease, COPD, strokes, and diabetes in Nepal. Factors explaining this trend include changes in lifestyle, urbanization, and possibly an increase in risk factors such as smoking and unhealthy diets. Despite government and international efforts to address healthcare needs, these diseases require chronic management and prevention strategies which are still developing in the region .
There is a significant 'mismatch' between the healthcare needs of Nepal's population and the global pharmaceutical market, as identified by the UK government. This discrepancy stems from insufficient incentives for pharmaceutical companies to develop medicines for diseases that predominantly affect low-income regions. Additionally, even when such medicines exist, the financial constraints make them inaccessible to the populations that need them most .
Health camps are crucial in managing both infectious and non-communicable diseases in Nepal by providing early diagnosis and initiating timely therapy. This is vital for reducing long-term morbidity and mortality, given the limited access to healthcare facilities in remote areas. These camps help bridge the gap between healthcare needs and available resources .
Controlling tuberculosis in Nepal involves several challenges, including extensive prevalence with about 45% of the population infected, with many cases being of the infectious type. Despite the implementation of the DOTS program, which has reduced death rates, 5,000 to 7,000 people still die annually. Contributing factors include inadequate healthcare infrastructure, lack of access to medicines, and insufficient incentives for pharmaceutical companies to develop targeted treatments for diseases that primarily affect poorer nations .